Magnetar Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,935
| Closed | -$1.1M | – | 1047 |
|
|
2025
Q1 | $1.1M | Buy |
+9,935
| New | +$1.1M | 0.01% | 326 |
|
|
2024
Q4 | – | Sell |
-2,732
| Closed | -$315K | – | 729 |
|
|
2024
Q3 | $315K | Buy |
+2,732
| New | +$315K | 0.01% | 396 |
|
|
2020
Q4 | – | Sell |
-19,009
| Closed | -$1.83M | – | 832 |
|
|
2020
Q3 | $1.83M | Buy |
+19,009
| New | +$1.83M | 0.03% | 266 |
|
|
2020
Q1 | – | Sell |
-2,491
| Closed | -$268K | – | 574 |
|
|
2019
Q4 | $268K | Buy |
+2,491
| New | +$268K | 0.01% | 458 |
|